MannKind Corp.
28903 North Avenue Paine
Valencia,
CA 91355
United States - Map
Phone: 661-775-5300
Web Site: http://www.mannkindcorp.com
| MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diseases, such as diabetes and cancer. Its lead product candidate, AFRESA, a rapid-acting insulin that has completed phase 3 clinical trials for the treatment of diabetes in the United States, Europe, and Japan. The companys lead product candidates also include MKC1106-PP, which is in phase I clinical trial for the treatment of various solid-tumor cancers, including ovarian, colorectal, pancreatic, renal, breast, non-small cell lung and prostate carcinomas, glioblastoma, and melanoma. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Alfred E. Mann , 83
Founder, Chairman and Chief Exec. Officer |
$
1.15M |
$
0 | Mr. Hakan S. Edstrom B.Sc., M.B.A., 58
Pres, Chief Operating Officer |
$
879.00K |
$
0 | Mr. Matthew J. Pfeffer CPA, 51
Chief Financial Officer, Principal Accounting Officer and Corp. VP |
$
326.00K |
$
0 | Dr. Juergen A. Martens Ph.D., 53
Chief Technical Officer and Corp. VP of Operations |
$
448.00K |
$
0 | Dr. Peter C. Richardson , 49
Chief Scientific Officer and Corp. VP |
$
543.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.78% Nasdaq 
Profile
